Daily multivitamin improved global cognition

As the second leading cause of death in Australia¹ and one of the major causes of disability and dependency among older people globally, dementia is a public health priority². There are currently 1 in 12 Australians aged 65 years and over living with dementia, with women making up nearly two-thirds of this number¹.

Largely attributed to population growth and ageing, the prevalence of dementia is estimated to almost triple by 2050, from 57.4 million to 152.8 million worldwide³. Alarmingly, there is also growing concern about the impact of COVID-19 on cognitive function, with a 2023 study reporting rapid progression of dementia following infection⁴.

Given the overwhelming prevalence of this debilitating disease and the absence of a cure⁵, identifying effective strategies to preserve cognitive function is of pressing concern.